JDRF (The Juvenile Diabetes Research Foundation) logo

JDRF (The Juvenile Diabetes Research Foundation)

North America, New York, United States, New York

Description

JDRF is a global organization dedicated to funding type 1 diabetes (T1D) research.

Investor Profile

JDRF (The Juvenile Diabetes Research Foundation) has backed more than 10 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 50% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Canada, Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Diabetes.
  • Led 1 rounds in the past year.

Stage Focus

  • Grant (80%)
  • Series A (10%)
  • Series Unknown (10%)

Country Focus

  • United States (70%)
  • Canada (20%)
  • Sweden (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Diabetes
  • Medical
  • Pharmaceutical
  • Gamification
  • Gaming
  • Online Games
  • Genetics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JDRF (The Juvenile Diabetes Research Foundation) frequently co-invest with?

AM
Europe, Zug, Switzerland, Baar
Co-Investments: 1
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
The Leona M. and Harry B. Helmsley Charitable Trust
North America, South Dakota, United States, Sioux Falls
Co-Investments: 1
W.L. Gore & Associates
North America, New Jersey, United States, Newark
Co-Investments: 1
Toronto Innovation Acceleration Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
Co-Investments: 1
Orion Healthcare Equity Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Centre for Drug Research and Development
North America, British Columbia, Canada, Vancouver
Co-Investments: 1

What are some of recent deals done by JDRF (The Juvenile Diabetes Research Foundation)?

Ahead Therapeutics

Barcelona, Catalonia, Spain

Ahead Therapeutics is a biotech company that uses a proprietary technology to develop treatments for different auto-immune disorders.

BiotechnologyHealth CarePharmaceutical
GrantJan 30, 2026
Blue Circle Health

Boston, Massachusetts, United States

Blue Circle Health is a nonprofit diabetes clinic that provides medical care and support for people living in under-resourced communities.

Health CareMedicalNon Profit
GrantJan 15, 2026
Amount Raised: $1,500,000
Invictus Therapeutics

West Warwick, Rhode Island, United States

Invictus Therapeutics develops next-generation insulin analogs for pump and automated insulin delivery systems.

BiopharmaBiotechnologyClinical TrialsDiabetesHealth CareManufacturingMedicalMedical DevicePharmaceuticalTherapeutics
GrantJan 12, 2026
SyntaxBio

Chicago, Illinois, United States

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

BiotechnologyMedicalProduct Research
GrantDec 10, 2025
Amount Raised: $856,250
University of Michigan

Ann Arbor, Michigan, United States

The University of Michigan is a public research university offering education, innovation, and global business engagement.

E-LearningEducationHigher EducationUniversities
GrantApr 23, 2025
Diatech Diabetes

Memphis, Tennessee, United States

Diatech Diabetes is a developer of monitoring systems to personalize insulin delivery for patients with diabetes.

DiabetesHealth CareMedicalMedical Device
GrantJun 22, 2023
Zucara Therapeutics

Vancouver, British Columbia, Canada

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

BiotechnologyDiabetesPharmaceutical
GrantJun 15, 2023
Amount Raised: $2,000,000
Diamyd Medical

Stockholm, Stockholms Lan, Sweden

Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.

Biotechnology
GrantApr 4, 2023
Amount Raised: $5,000,000
Neurodon

Crown Point, Indiana, United States

Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.

BiotechnologyHealth CareMedicalPharmaceutical
GrantJun 3, 2022
Amount Raised: $920,000
TidePool

San Francisco, California, United States

Tidepool offers a game-based technology that enables users to decode personality traits, emotions, and short-term cognitive processes.

GamificationGamingOnline Games
GrantDec 14, 2018
Amount Raised: $6,000,000

Find More Investors Like JDRF (The Juvenile Diabetes Research Foundation)

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

JDRF (The Juvenile Diabetes Research Foundation) | Pipeseed